Published in J Clin Invest on September 11, 2017
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res (2001) 6.15
Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest (2003) 4.58
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res (2007) 4.53
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res (2006) 4.38
Cardiac fibroblast: the renaissance cell. Circ Res (2009) 4.01
Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature (1998) 3.65
Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem (2001) 3.32
Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation (2002) 3.20
Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest (2007) 3.16
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation (2007) 3.07
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res (2010) 2.89
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest (2010) 2.64
Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res (2006) 2.59
The myofibroblast: paradigm for a mechanically active cell. J Biomech (2009) 2.53
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest (2009) 2.46
Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol (2010) 2.35
Origin of cardiac fibroblasts and the role of periostin. Circ Res (2009) 2.33
Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol (2004) 2.17
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res (2010) 1.94
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest (2011) 1.94
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
The extracellular matrix: at the center of it all. J Mol Cell Cardiol (2009) 1.64
Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation. J Mol Cell Cardiol (2003) 1.48
A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. Genesis (2009) 1.44
Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am J Respir Cell Mol Biol (2006) 1.38
Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis (2011) 1.35
New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol (2010) 1.29
Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene (2004) 1.24
Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta. Nucleic Acids Res (2003) 1.21
Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res (2014) 1.20
TGF-β: the master regulator of fibrosis. Nat Rev Nephrol (2016) 1.19
Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail (2009) 1.17
Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways. Am J Transplant (2006) 1.14
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2016) 1.13
Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling. J Cell Physiol (2008) 1.09
Future treatments in systemic sclerosis. J Dermatol (2010) 1.06
Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials (2005) 1.04
Caspase-3 protects stressed organs against cell death. Mol Cell Biol (2012) 1.03
Hepatic fibrogenesis: from within and outwith. Toxicology (2008) 0.97
Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun (2016) 0.96
A far-upstream AP-1/Smad binding box regulates human NOX4 promoter activation by transforming growth factor-β. Gene (2014) 0.95
Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling. Mol Cell Biol (2015) 0.90
Pathological ventricular remodeling: therapies: part 2 of 2. Circulation (2013) 0.90
Pleiotrophin induces formation of functional neovasculature in vivo. Biochem Biophys Res Commun (2005) 0.89
Synergistic roles of scleraxis and Smads in the regulation of collagen 1α2 gene expression. Biochim Biophys Acta (2012) 0.89
Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations. J Mol Cell Cardiol (2015) 0.87
Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res (2016) 0.87
Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice. Hum Mol Genet (2014) 0.85
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov (2016) 0.82
Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death. PLoS One (2015) 0.82
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer. Cancer Discov (2016) 0.82
Strategies for TGF-beta modulation: a review of recent patents. Expert Opin Ther Pat (2009) 0.80
GATA4 regulates Fgf16 to promote heart repair after injury. Development (2016) 0.79
Fibroblast-Specific Genetic Manipulation of p38 MAPK in vivo Reveals its Central Regulatory Role in Fibrosis. Circulation (2017) 0.78
New frontiers in fibrotic disease therapies: The focus of the Joan and Joel Rosenbloom Center for Fibrotic Diseases at Thomas Jefferson University. Matrix Biol (2016) 0.78
Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem (2014) 0.77
Morphometric analysis of coronary capillaries during physiologic myocardial growth and induced cardiac hypertrophy: a review. Int J Microcirc Clin Exp (1989) 0.76
Smad3-mSin3A-HDAC1 Complex is Required for TGF-β1-Induced Transcriptional Inhibition of PPARγ in Mouse Cardiac Fibroblasts. Cell Physiol Biochem (2016) 0.76
SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Sci Rep (2017) 0.75